| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000019204 |
| Receipt No. | R000021814 |
| Official scientific title of the study | Induction of follicle development in poor responder patients based on suppression of Hippo signaling |
| Date of disclosure of the study information | 2015/10/02 |
| Last modified on | 2017/04/12 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Induction of follicle development in poor responder patients based on suppression of Hippo signaling | |
| Title of the study (Brief title) | Induction of follicle development in poor responder. | |
| Region |
|
|
| Condition | ||
| Condition | Poor responder infertility patients | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The success of IVF treatment in poor responder patients is low due to decreases in the number of retrieved oocytes. Recent study demonstrated that suppression of Hippo signaling in somatic cells of ovarian follicles induced secondary follicle growth, resulting in increases in the number of antral follicles. To improve the outcome of IVF treatment in poor responder patients, we establish the method to increases the number of retrieved oocytes by induction of secondary follicle growth through ovarian tissue removal and fragmentation with in vitro culture followed by auto-transplantation. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Phase III |
| Assessment | |
| Primary outcomes | Comparison of the number of oocytes retrieved after ovarian stimulation with those of base line numbers. |
| Key secondary outcomes | Comparison of proportions of fertilization, pregnancy and abortion with those of base line levels. Comparison of the levels of molecular markers reflecting the results of Hippo signal suppression in ovarian tissues and serum before and after culture and grafting operation, respectively. Also, we count the number of secondary follicles in grafting tissues by histological analysis. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Historical |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | 1) Correct serum from the patients before surgery to measure molecular markers to ensure suppression of Hippo signaling.
2) Excise one side of whole ovary or partial ovarian tissues under laparoscopic surgery. After removal of medulla tissues to prepare ovarian cortex, the ovarian cortex was dissected into 1x1cm with 1-2mm thickness of tissue stripes. Among the cortical tissue stripes, 2-3 stripes are further cut into 1-2mm cubes. Surplus cortical tissue stripes are cryopreserved using vitrification or slow freezing method. 3) Nine to ten of ovarian cubes are put onto cell culture insert and cultured for several hours to suppress Hippo signaling. Collect some ovarian cubes before and after culture to ensure suppression of Hippo signaling. 4) After culture, ovarian cubes are washed extensively by saline. These cubes are auto-transplanted beneath of the serosa of both Fallopian tubes, remaining ovaries and/or Douglus' pouch. In some patients who have relatively better ovarian reserve, we directly cut ovarian cortex inside of the body or scratch ovarian cortex to induce physical stimulation to the ovary. From the contra lateral side of ovary, we also remove a part of ovarian cortical tissues and cut into 1-2 mm cubes. Immediately after fragmentation of ovarian corticies, these ovarian cubes are grafted without cultures. 5) Correct serum from the patients after surgery to measure molecular markers to ensure suppression of Hippo signaling. After grafting, patients receive ovarian stimulation using gonadotropin drugs to stimulate follicle growth and retrieve oocytes. Mature oocytes are fertilized by in vitro fertilization and preimplantation embryos are transplant into uterus. The treatment continues for 1-2 years. If first auto-transplantation is not successful and patients have cryopreserved ovarian tissues, patients can repeat these procedures |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | All following four features must be present:
1) Advanced maternal age (=>40 years) or any other risk factor for POR 2) A previous POR (<=3 oocytes with a conventional stimulation protocol) 3) An abnormal ovarian reserve test (i.e. AFC, 5-7 follicles or AMH, 0.5-1.1 ng/ml). 4) Married women |
|||
| Key exclusion criteria | 1)Patients with severe ovarian dysfunction who can not retrieve oocytes after ovarian stimulation.
2)Patients with high risk for laparoscopy. 3)Patients who can not obtain written informed consent. 4)Patients judged to be inappropriate for the study by the physicians. |
|||
| Target sample size | 200 | |||
| Research contact person | |
| Name of lead principal investigator | Atsushi Tanaka |
| Organization | Saint Mother Hospital |
| Division name | |
| Address | 4-9-12 Orio Yahatanishiku, Kitakyusyu, Fukuoka, JAPAN |
| TEL | 093-601-2000 |
| incho@stmother.com | |
| Public contact | |
| Name of contact person | Atsushi Tanaka |
| Organization | Saint Mother Hospital |
| Division name | |
| Address | 4-9-12 Orio Yahatanishiku, Kitakyusyu, Fukuoka, JAPAN |
| TEL | 093-601-2000 |
| Homepage URL | |
| incho@stmother.com | |
| Sponsor | |
| Institute | Saint Mother Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Saint Mother Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | セントマザー産婦人科医院(福岡県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021814 |